PX-316


CAS No. : 253440-95-8

253440-95-8
Price and Availability of CAS No. : 253440-95-8
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-119134
M.Wt: 584.72
Formula: C28H57O10P
Purity: >98 %
Solubility:
Introduction of 253440-95-8 :

PX-316 is an Akt inhibitor. PX-316 can phosphorylate Akt, but does not inhibit the phosphorylation of PDK1 or PKC. PX-316 uniquely increases the expression of a group of mitochondrial-related genes. PX-316 can be used for the study of colon cancer and breast cancer[1]. In Vitro:PX-316 (0-15 μM, 2 h) specifically inhibits Akt (IC50 = 1.7 μM) activation in HT-29 human colon cancer cells without affecting upstream kinase PDK1 or related kinase PKC[1].
PX-316 (0.5-20 μM, 3 days) inhibits the proliferation of MCF-7 and HT-29 cells[1].
In Vivo:PX-316 (37.5-150 mg/kg, i.p., once) effectively inhibits the Akt signaling pathway and its downstream targets in HT-29 cells xenograft mice, and the inhibitory effect is maintained even after multiple administrations[1].
PX-316 (50-150 mg/kg, i.p., once for 4-10 days) demonstrates dose- and regimen-dependent antitumor activity in two different mice xenograft models of human tumors (MCF-7 and HT-29)[1].

Your information is safe with us.